Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
TRIUMPH-1 (NCT05929066), the Phase 3 registration trial for the obesity indication, reported topline results on May 21, 2026 : average weight loss of 28.3% at 80 weeks at the highest dose in 2,339 participants, versus 2.2% on placebo, and 30.3% at 104 weeks among participants with a BMI of 35 or above who continued in a pre-specified extension
Thats where a telehealth option helps
Include protein in every meal Include 20-30 grams of protein in each main meal
TSA 3-1-1 Liquid Rule Exemptions for Medicine Injectable medications like semaglutide and tirzepatide are exempt from the 3-1-1 Liquids Rule, so you dont need to pack them in your Ziploc along with all your toiletries
-webp.webp?width=1920&height=1281&name=Culver%20City%20Treatment%20room%20(1)-webp.webp)
US$ 29.28
US$ 24.59
US$ 28.96
US$ 20.49
US$ 28.99
US$ 26.01
US$ 20.87
US$ 23.45
US$ 25.67
US$ 23.81
